Firialta 20mg

Content

• Formulation: Yellow, oval-oblong, film-coated tablet marked with "20" on one side and "FI" on the other side

• Strength: Each tablet contains 20mg of finerenone

• Packaging: Available in bottles of 30 tablets 

 Indications

• Chronic Kidney Disease (CKD) associated with Type 2 Diabetes (T2D): To reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage renal disease (ESRD), cardiovascular (CV) death, non-fatal myocardial infarction (MI), and hospitalization for heart failure in adults with CKD associated with T2D 

Instructions 

• Dosage:

  • 20mg once daily for patients with eGFR ≥60 mL/min/1.73 m²

  • 10mg once daily for patients with eGFR between 25–59 mL/min/1.73 m²